Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Casinvent Pharma Logo
Casinvent Pharma Growth Score
88
CB Rank
52943
Heat Score
63
Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.
Founded
obfuscation
PrivateGrant Brno, Jihomoravsky kraj, Czech Republic1-10 casinvent.com/
Medical
Oncology
Pharmaceutical
Precision Medicine
Overview

Casinvent Pharma
Total Funding
obfuscation
Growth Score
88
Heat Score
63

Total Funding
obfuscation
Grant raised
obfuscation
Growth Score88
-3 pts
in past quarter
Heat Score 63
6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Casinvent Pharma

CB Rank
52943
Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.
Founded
obfuscation
PrivateGrant Brno, Jihomoravsky kraj, Czech Republic1-10 casinvent.com/
Medical
Oncology
Pharmaceutical
Precision Medicine

Funding Rounds

Grant
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Casinvent
Operating Status Active
Company Type For Profit
About the Company
Casinvent Pharma provides pharmaceutical solutions for the treatment of selected malignancies. It is based on the use of proprietary selective inhibitors of enzymes from the CK1 family for leukemia cell migration into lymphoid organs.
Phone Number +42- 072-899-5850
Contact Email info@casinvent.com
Predictions & Insights

Growth Insight

See this Growth Insight
Casinvent Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Selective Small-Molecule Inhibitors of Casein Kinase 1 (CK1)
Small-molecule compounds designed to selectively inhibit specific isoforms of the CK1 family of serine/threonine kinases involved in cancer cell resistance mechanisms.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
1
obfuscation
EIC AcceleratorGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
1
obfuscation
EIC AcceleratorGrant
obfuscation
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
1
obfuscation
EIC AcceleratorGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
EIC Accelerator Logo
EIC Accelerator
Yes
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
—
EIC Accelerator Logo
EIC Accelerator
Yes
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
—
EIC Accelerator Logo
EIC Accelerator
Yes
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
—
EIC Accelerator Logo
EIC Accelerator
Yes
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
—
EIC Accelerator Logo
EIC Accelerator
Yes
Grant - Casinvent Pharma Logo
Grant - Casinvent Pharma
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News

News and Press

News•Jul 16, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 16, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 31, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$71.8KThis year, Casinvent Pharma is projected to spend $71.8K on IT, according to Aberdeen.

Active Website Tech Count

7Casinvent Pharma is actively using 7 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  Apple Mobile Web Clips Icon.

Total IP

1Casinvent Pharma has 1 registered trademark in the 'Chemical substances' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Casinvent Pharma's headquarters? Casinvent Pharma is located in Brno, Jihomoravsky kraj, Czech Republic.Who invested in Casinvent Pharma? Casinvent Pharma has 9 investors including EIC Accelerator and  Holecek Family Foundation.When was the last funding round for Casinvent Pharma? Casinvent Pharma closed its last funding round on
obfuscation
from a Grant round.Who are Casinvent Pharma's competitors? Alternatives and possible competitors to Casinvent Pharma may include Pfizer, Canton Strategic Holdings, and  Relay Therapeutics.How much funding has Casinvent Pharma raised to date? Casinvent Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|